Funding programme: Horizon Europe Cancer Mission
Call: [HORIZON-MISS-2022-CANCER-01]
Project coordinator: ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (CERTH)
Other partners: La Fundación para la Investigación del Hospital Clínico de la Comunidad Valenciana (INCLIVA), European Cancer Patient Coalition (ECPC), European Society of Digestive Oncology (ESDO), Youth Cancer Europe (YCE), Greek Ministry of Health, Lithuanian Ministry of Health, European Forum for Primary Care (EFPC), Regional Development Fund of Central Macedonia (RDFCM), Agencia Regionale per la Salute ed il Sociale (AReSS Puglia), Erevnitiko Panepistimiako Institouto Systimaton Epikoinonion kai Ypolgiston-EMP (ICCS), Lithuanian University of Health Sciences (LSMU), Institutul Oncologic Prof. Dr. Alexandru Trestioreanu (IOB), Exus Software Monoprosopi Etairia Periorismenis Evthinis, Universidad de la Rioja, Aristotle University of Thessaloniki, Innovation Sprint (iSprint), Catalink Limited, UniSystems Luxembourg, Nutrinomics, EY Advisory SpA, Beia Consult International SRL, SYNYO GmbH, Diadikasia Business Consulting, Institut Català d’Oncologia, Pagalbos Onkologiniams Ligoniams Asociacija (POLA – LT).
Role of EUREGHA: will provide support to Work Package 2 on “Participatory Implementation Research Framework and System Co-Design”, Work Package 5 on “Financial, Clinical and Political Analyses for ONCODIR Adoption”, Work Package 6 on “Long-lasting Validation of ONCODIR Solutions and Methodologies and End-user upskilling”, and Work Package 7 on “Synergistic Impact creation & Bottom-up Innovation”
Total budget: €7.893.636,25 EUREGHA budget: €134.575,00
Stemming from the specific risk factors identified with colorectal cancer (CRC), ONCODIR: Evidence-based Participatory Decision Making for Cancer Prevention through implementation research project integrates multidisciplinary research methods from health policy analytics, social and behavioural science, artificial intelligence (AI) – powered multi-omics and retrospective data analytics, as well as decision support theories to deliver evidence-based cancer prevention programmes and innovative AI-powered personalised prevention approaches. The coherent technological ecosystem that ONCODIR is developing is based on robust AI trustworthiness and privacy preserving principles to deploy recommendation services that will be specified by citizens, health policy actors and Social Sciences and Humanities (SSH) experts, during three design thinking workshops. SSH research will address aspects such as the life-status, nutritional and social habits in tandem with Economics, Sociology and Local/Regional Cultural Identity and Ethics. ONCODIR’s results will be validated in three Laboratory Integration Tests (LITs) and three Large-scale Intervention Pilots (LIPs) in five EU member states, with the active involvement of medical scientists, health care providers, foundations, and consortium experts.
